Nov 22 (Reuters) - aXichem AB (publ) AXIC.ST :
* AXICHEM SIGNS AGREEMENT WITH CALDIC DENMARK REGARDING
MARKETING
AND DISTRIBUTION OF AXIVITE IN THE NORDIC REGION
* UNDER AGREEMENT CALDIC DENMARK WILL HAVE EXCLUSIVE RIGHT
TO
MARKET AND SELL AXICHEM'S UNIQUE SYNTHETIC CAPSAICIN
PRODUCT,AXIVITE, IN DENMARK, FINLAND, NORWAY AND SWEDEN
* AIM TO INTRODUCE A MARKET READY PRODUCT DURING 2022
* AXIVITE IS PROVEN IN CLINICAL STUDIES TO HAVE A POSITIVE
EFFECT
ON GUT HEALTH AS WELL AS METABOLISM, AND ITS THERMOGENIC EFFECT
SUPPORTS AN IMPROVED BODY COMPOSITION
Source text for Eikon: ID:nWkr7XL6CN
Further company coverage: AXIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))